Staff Directory

Last Updated

09/10/2017

Email
Telephone
01522 83 7760
Post
University of Lincoln
Brayford Pool
Lincoln
Lincolnshire
LN6 7TS
United Kingdom

About Nicholas Blagden

Prof Nicholas Blagden holds the Chair in Pharmaceutics at the School of Pharmacy, University of Lincoln from December 2012.   He has a joint honours degree in chemistry and physics, (1984-1987), and a DPhil in chemical physics (1992) under the supervision of Professor Kenneth Seddon.  Prior taking up his current post Blagden was a Reader in Solid State Pharmaceutics at the Univeristy of Bradford (2001 to 2012), and has also worked as a Crystallisation Specialist for Avecia (2000-2001). He has undertaken postdoctoral work in crystal growth, crystal engineering and polymorphism at UMIST with Professor Roger Davey (1995-2000) and bio-mineralization with Professor Brigid Heywood (1993-1995).  Blagden has published two book chapters, over sixty papers, four reviews, holds two patents, and has given 42 invited lectures to both academic and industrial conferences.  He has chaired sessions at the 2003 congress of the International Union of Crystallography on “insitu monitoring of crystallization”, 2006 BCA spring meeting on “crystal engineering”, and 2008 BCA session on “x-ray diffraction studies of crystallisation.” Blagden has specialized in the relationship between molecular self-association observed in solution with the molecular assembly of the solid phase, and the impact this has on the physico-chemical or biophysical behaviour of materials. His research has contributed a number of notable first in the area of polymorph selection, pre-nucleation, co-crystals,  molecular solid nano particles, and. the manipulation of morphology using nucleation templates, Recent work has focused on the design and the crystal growth of co-crystals to improve a drugs bio availability. His early work on polymorphism has been recognized by the award of the British Association of Crystal Growth Young Scientist medal in 1997. He has served on the British Association of Crystal Growth Committee and was involved in Nano-factory within the Yorkshire region.

Department Responsibilities

Member Senior Management Team Pharmacy Module Lead Drug Formulation and Development

Subject Specialism

Physical Pharmaceutics, Crystallisation and Crystal Engineering

Qualifications

  • HEA Fellow — HEA, 2007
  • MRSC — Royal Society Chemistry, 1998
  • DPhil — Sussex, 1992
  • BSc (hons) — Staffordshire, 1988

Consultancy

COST action Crystallise, lead crystal growth

Orcid ID

0000-0001-5363-6748

Research Interests

  • Crystal Engineering

  • Crystallization

  • insilico solid state design

  • molecular self assembly

  • Pharmaceutics

Research Groups Memberships

  • Lincoln Institue of Health
  • Drug Discovery and Development

Research Projects

  • Salt formation of drugs — GSK in
  • Micro Fluidics for crystal screening — Astra Zeneca in
  • Peptide Complexes a combined synthesis and crystal engineering approach — UOL-RIF in
  • API nano medicines using fluidics approach — UOL-RIF in
  • Crystal Engineering for proton conduction — UOL in

Research in the Lincoln Repository


Professional Affiliations

  • BACG — member
  • BCA — member